No evidence for an association between the 5-hydroxytryptamine 5-HT2a receptor gene and schizophrenia in Kuwaiti Arabs

被引:13
作者
Haider, MZ
Zahid, MA
机构
[1] Kuwait Univ, Fac Med, Dept Pediat, Clin Genet Grp, Safat 13110, Kuwait
[2] Kuwait Univ, Fac Med, Dept Psychiat, Safat 13110, Kuwait
[3] Hosp Psychol Med, Kuwait, Kuwait
关键词
Kuwait; polymerase chain reaction; polymorphism; schizophrenia; serotonin;
D O I
10.1046/j.1440-1819.2002.01037.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The prevalence of T102C polymorphism of the 5-hydroxytryptamine 5-HT2a receptor gene has been investigated using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method in 80 Kuwaiti Arabs with schizophrenia and in 109 normal healthy controls with a similar ethnic background. There was no significant difference in the frequency of T102 polymorphism in the Kuwaiti cohort of schizophrenia patients and the controls (P = 0.23). The data from Kuwaiti Arabs (although our sample size is relatively small) support the findings from some other populations (Caucasians, Japanese), in which a lack of association has been found between T102C polymorphism and the onset of schizophrenia.
引用
收藏
页码:465 / 467
页数:3
相关论文
共 21 条
  • [1] ALAWADI SA, 1985, CLIN GENET, V27, P483
  • [2] Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine
    Arranz, MJ
    Munro, J
    Owen, MJ
    Spurlock, G
    Sham, PC
    Zhao, J
    Kirov, G
    Collier, DA
    Kerwin, RW
    [J]. MOLECULAR PSYCHIATRY, 1998, 3 (01) : 61 - 66
  • [3] Lack of allelic association between 102T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese
    Chen, CH
    Lee, YR
    Wei, FC
    Koong, FJ
    Hwu, HG
    Hsiao, KJ
    [J]. PSYCHIATRIC GENETICS, 1997, 7 (01) : 35 - 38
  • [4] Hawi Z, 1997, AM J MED GENET, V74, P370, DOI 10.1002/(SICI)1096-8628(19970725)74:4<370::AID-AJMG6>3.0.CO
  • [5] 2-T
  • [6] He L, 1999, AM J MED GENET, V88, P95, DOI 10.1002/(SICI)1096-8628(19990205)88:1<95::AID-AJMG17>3.3.CO
  • [7] 2-F
  • [8] Inayama Y, 1996, AM J MED GENET, V67, P103, DOI 10.1002/(SICI)1096-8628(19960216)67:1<103::AID-AJMG18>3.0.CO
  • [9] 2-S
  • [10] Inayama Y, 1994, NEUROPSYCHOPHARMACOL, V10, P56